HopeStage
Back to all studies
RecruitingNCT07174947

Fluoxetine with immunotherapy in liver and bile duct cancer

About this titleRead the official source — NCT07174947
Medication studyAges 18–80ChinaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

Listed locations
WenzhouSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
240
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
China
Age range
From 18 Years to 80 Years
Official registry ID
NCT07174947
Official title
Show the full official title

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety: A Randomized Controlled Clinical Trial

Recruitment & locations

Currently recruiting

Wenzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is First Affiliated Hospital of Wenzhou Medical University, a university.

Does this study involve medication?

Yes. The study involves medication, including Fluoxetine (drug) and Placebo.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies